Effects of granulocyte-colony stimulating factor (G-CSF) on diabetic cardiomyopathy in Otsuka Long-Evans Tokushima Fatty rats

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Lim, Young Hyo ^a   Joe, Jun Ho ^a   Jang, Ki Seok ^a   Song, Yi Sun ^a   So, Byung Im ^a   Fang, Cheng Hu ^a   Shin, Jinho ^a   Kim, Jung Hyun ^a   Lim, Heon Kil ^a   Kim, Kyung Soo ^a  

^a Hanyang University   (South Korea)

Author keywords

Cardiomyopathy; Diabetes mellitus; Doppler; Echocardiography; Fibrosis; Histology

Indexed keywords

CHOLESTEROL; GLUCOSE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; ELECTRON MICROSCOPY; FIBROSING ALVEOLITIS; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERSTITIUM; MALE; MYOFILAMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; RAT; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; COMPARATIVE STUDY; HEART FAILURE; HEART MUSCLE FIBROSIS; HUMAN; LONG EVANS RAT; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; ENDOMYOCARDIAL FIBROSIS; GRANULOCYTE COLONY-STIMULATING FACTOR; HEART FAILURE; HUMANS; MALE; RATS; RATS, INBRED OLETF; RATS, LONG-EVANS;

EID: 80054053514     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-92     Document Type: Article

References (29)

1. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972, 30(6):595-602. 10.1016/0002-9149(72)90595-4, 4263660.
2. Mizushige K, Yao L, Noma T, Kiyomoto H, Yu Y, Hosomi N, Ohmori K, Matsuo H. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation 2000, 101(8):899-907.
3. Takenaka K, Sakamoto T, Amano K, Oku J, Fujinami K, Murakami T, Toda I, Kawakubo K, Sugimoto T. Left ventricular filling determined by Doppler echocardiography in diabetes mellitus. Am J Cardiol 1988, 61(13):1140-1143. 10.1016/0002-9149(88)90149-X, 3364373.
4. Robillon JF, Sadoul JL, Jullien D, Morand P, Freychet P. Abnormalities suggestive of cardiomyopathy in patients with type 2 diabetes of relatively short duration. Diabete Metab 1994, 20(5):473-480.
5. Boyer JK, Thanigaraj S, Schechtman KB, Perez JE. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol 2004, 93(7):870-875. 10.1016/j.amjcard.2003.12.026, 15050491.
6. Zabalgoitia M, Ismaeil MF, Anderson L, Maklady FA. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am J Cardiol 2001, 87(3):320-323. 10.1016/S0002-9149(00)01366-7, 11165968.
7. Wachter R, Luers C, Kleta S, Griebel K, Herrmann-Lingen C, Binder L, Janicke N, Wetzel D, Kochen MM, Pieske B. Impact of diabetes on left ventricular diastolic function in patients with arterial hypertension. Eur J Heart Fail 2007, 9(5):469-476. 10.1016/j.ejheart.2007.01.001, 17303471.
8. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27(5):1047-1053. 10.2337/diacare.27.5.1047, 15111519.
9. Marwick TH. Diabetic heart disease. Heart 2006, 92(3):296-300. 1860832, 16159978.
10. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 2004, 25(4):543-567. 10.1210/er.2003-0012, 15294881.
11. Eckel J, Reinauer H. Insulin action on glucose transport in isolated cardiac myocytes: signalling pathways and diabetes-induced alterations. Biochem Soc Trans 1990, 18(6):1125-1127.
12. Gotzsche O. Myocardial cell dysfunction in diabetes mellitus A review of clinical and experimental studies. Diabetes 1986, 35(10):1158-1162. 10.2337/diabetes.35.10.1158, 3530845.
13. Garvey WT, Hardin D, Juhaszova M, Dominguez JH. Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy. Am J Physiol 1993, 264(3 Pt 2):H837-844.
14. Harada M, Qin Y, Takano H, Minamino T, Zou Y, Toko H, Ohtsuka M, Matsuura K, Sano M, Nishi J, Iwanaga K, Akazawa H, Kunieda T, Zhu W, Hasegawa H, Kunisada K, Nagai T, Nakaya H, Yamauchi-Takihara K, Komuro I. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 2005, 11(3):305-311. 10.1038/nm1199, 15723072.
15. Baldo MP, Davel AP, Damas-Souza DM, Nicoletti-Carvalho JE, Bordin S, Carvalho HF, Rodrigues SL, Rossoni LV, Mill JG. The Antiapoptotic Effect of Granulocyte Colony-stimulating Factor Reduces Infarct Size and Prevents Heart Failure Development in Rats. Cell Physiol Biochem 2011, 28(1):33-40. 10.1159/000331711, 21865846.
16. Minatoguchi S, Takemura G, Chen XH, Wang N, Uno Y, Koda M, Arai M, Misao Y, Lu C, Suzuki K, Goto K, Komada A, Takahashi T, Kosai K, Fujiwara T, Fujiwara H. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 2004, 109(21):2572-2580. 10.1161/01.CIR.0000129770.93985.3E, 15123535.
17. Adachi Y, Imagawa J, Suzuki Y, Yogo K, Fukazawa M, Kuromaru O, Saito Y. G-CSF treatment increases side population cell infiltration after myocardial infarction in mice. J Mol Cell Cardiol 2004, 36(5):707-710. 10.1016/j.yjmcc.2004.03.005, 15135666.
18. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research. PLoS Biol 2010, 8(6):e1000412. 10.1371/journal.pbio.1000412, 2893951, 20613859.
19. Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 1992, 41(11):1422-1428. 10.2337/diabetes.41.11.1422, 1397718.
20. Asghar O, Al-Sunni A, Khavandi K, Khavandi A, Withers S, Greenstein A, Heagerty AM, Malik RA. Diabetic cardiomyopathy. Clin Sci (Lond) 2009, 116(10):741-760.
21. Strunz CM, Matsuda M, Salemi VM, Nogueira A, Mansur AP, Cestari IN, Marquezini MV. Changes in cardiac heparan sulfate proteoglycan expression and streptozotocin-induced diastolic dysfunction in rats. Cardiovasc Diabetol 2011, 10:35. 10.1186/1475-2840-10-35, 3100243, 21518435.
22. Rodrigues B, Rosa KT, Medeiros A, Schaan BD, Brum PC, De Angelis K, Irigoyen MC. Hyperglycemia can delay left ventricular dysfunction but not autonomic damage after myocardial infarction in rodents. Cardiovasc Diabetol 2011, 10:26. 10.1186/1475-2840-10-26, 3084163, 21470409.
23. Hamamoto M, Tomita S, Nakatani T, Yutani C, Yamashiro S, Sueda T, Yagihara T, Kitamura S. Granulocyte-colony stimulating factor directly enhances proliferation of human troponin I-positive cells derived from idiopathic dilated cardiomyopathy through specific receptors. J Heart Lung Transplant 2004, 23(12):1430-1437. 10.1016/j.healun.2003.09.031, 15607674.
24. Tomita S, Ishida M, Nakatani T, Fukuhara S, Hisashi Y, Ohtsu Y, Suga M, Yutani C, Yagihara T, Yamada K, Kitamura S. Bone marrow is a source of regenerated cardiomyocytes in doxorubicin-induced cardiomyopathy and granulocyte colony-stimulating factor enhances migration of bone marrow cells and attenuates cardiotoxicity of doxorubicin under electron microscopy. J Heart Lung Transplant 2004, 23(5):577-584. 10.1016/j.healun.2003.06.001, 15135374.
25. Avalos BR. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 1996, 88(3):761-777.
26. Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood 1991, 78(11):2791-2808.
27. Berliner N, Hsing A, Graubert T, Sigurdsson F, Zain M, Bruno E, Hoffman R. Granulocyte colony-stimulating factor induction of normal human bone marrow progenitors results in neutrophil-specific gene expression. Blood 1995, 85(3):799-803.
28. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410(6829):701-705. 10.1038/35070587, 11287958.
29. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001, 7(4):430-436. 10.1038/86498, 11283669.